1. Home
  2. NOTV vs BNKK Comparison

NOTV vs BNKK Comparison

Compare NOTV & BNKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.08

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

BNKK

Bonk Inc.

N/A

Current Price

$1.35

Market Cap

11.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
NOTV
BNKK
Founded
1974
2018
Country
United States
United States
Employees
N/A
10
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.8M
11.9M
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
NOTV
BNKK
Price
$0.08
$1.35
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$1.50
N/A
AVG Volume (30 Days)
59.5M
423.5K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
49.64
N/A
EPS
N/A
N/A
Revenue
$547,656,000.00
N/A
Revenue This Year
$5.28
N/A
Revenue Next Year
$5.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
511.19
N/A
52 Week Low
$0.08
$0.11
52 Week High
$2.44
$7.19

Technical Indicators

Market Signals
Indicator
NOTV
BNKK
Relative Strength Index (RSI) 31.45 28.58
Support Level N/A $0.12
Resistance Level $0.33 $2.90
Average True Range (ATR) 0.04 0.18
MACD -0.02 -0.02
Stochastic Oscillator 0.70 11.75

Price Performance

Historical Comparison
NOTV
BNKK

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About BNKK Bonk Inc.

Bonk Inc provides over-the-counter products and consumer products in the United States. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It sells its products through direct customers, distributors, retailers, and e-commerce websites. The company generates revenue through various channels, its primary sales include nostingz suncare products which are sold through e-commerce platforms, licensing revenues from Photocil and sales of the Safety Shot Beverage. The company has two reportable segments: the dietary and energy beverage business and digital assets, consisting of investing for growth in the appreciation of the asset. It derives the majority of the revenue from the dietary and energy beverage segment.

Share on Social Networks: